Eko Launches Cardiac Disease Detection Platform
Eko, a digital health company applying AI to address heart and lung disease, has launched the SENSORA Cardiac Disease Detection Platform.
Read MorePosted by Andy Lundin | Feb 23, 2023 | Cardiovascular |
Eko, a digital health company applying AI to address heart and lung disease, has launched the SENSORA Cardiac Disease Detection Platform.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Disease States |
The NCCHD in Japan and OmniTier detailed how the company’s genomic analysis platform improved diagnostic rates for rare diseases.
Read MorePosted by Andy Lundin | Jan 20, 2023 | Diagnostic Technologies |
Biomedical engineers say interstitial fluid could provide an excellent medium for early disease diagnosis or long-term health monitoring.
Read MorePosted by Andy Lundin | Jan 13, 2023 | Disease States |
Twist Bioscience and Centogene N.V. launched three NGS target enrichment panels to support rare disease and hereditary cancer diagnostics.
Read MorePosted by Chris Wolski | Dec 29, 2022 | Mass Spectrometry Instruments |
This technology could become a reality within a few years, and contains a key component called the whispering gallery mode microresonator.
Read More